MustGrow Biologics Corp. (MGROF)
MustGrow Biologics posts first significant revenue in ‘pivotal' Q1 report
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF)' first quarter 2025 earnings report was a pivotal milestone for the company as it reported significant sales revenue for the first time, analysts at Nobel Capital Markets have highlighted. Q1 marked the first full quarter since the company acquired NexusBioAg at the end of 2024.
MustGrow Biologics posts record first quarter revenue
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) has reported first quarter revenue of $3.8 million, a record for the company. The developer of regenerative farming solutions posted a gross profit for the quarter of $541.221 at a 14.3% gross margin.
MustGrow expands product line with three new biological solutions
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) has introduced three new biological products to its Canadian lineup following its acquisition of sales and distribution division NexusBioAg, the company said on Tuesday. The additions—EZ-Gro Max, EZ-Gro Cyto, and Rootella mycorrhizal inoculants—are designed to enhance crop health, increase yield potential, and improve resilience against environmental stress, MustGrow said in a statement.
MustGrow Biologics signs five-year deal for Canadian expansion - ICYMI
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) CEO Corey Giasson joined Proactive to discuss the company's latest five-year exclusive distribution agreement with Adjuvants Plus in Canada. Through its sales and distribution arm, NexusBioAg, MustGrow will now offer Adjuvants Plus products to Canadian farmers.
MustGrow distribution deal sets stage for successful US expansion, analysts believe
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) this week announced the signing of a five-year exclusive distribution agreement with Adjuvants Plus, a move welcomed by analysts at Noble Capital Markets. Per the agreement, MustGrow will distribute Adjuvants' product line across Canada through NexusBioAg.
MustGrow Biologics inks distribution deal with Adjuvants Plus
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) announced that it has signed a five-year exclusive distribution agreement with Canadian regenerative agriculture firm Adjuvants Plus. The company said that through its recently acquired Canadian sales and distribution division, NexusBioAg, it will distribute Adjuvants' product line across the country.
MustGrow Biologics announces closing of financing round
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) announced the completion of its previously disclosed non-brokered private placement of units, raising $2,585,000. The proceeds of the offering will be used for inventory production of its biofertilizer offering TerraSante, working capital and general corporate purposes.
MustGrow Biologics expands revenue, enhances sales reach through NexusBioAg acquisition, analysts believe
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF)' acquisition of NexusBioAg “dramatically changes” the revenue outlook for the company in 2025, analysts at Noble Capital Markets believe. Last week, the company announced it finalized the acquisition of NexusBio for a cash payment of approximately C$1.6 million and earn-out payments totalling a percentage of gross margin on certain itemized products sold by the company in 2025 and 2026.
MustGrow Biologics CEO discusses NexusBio acquisition and future plans – ICYMI
In a recent Q&A with Proactive, MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) CEO Corey Giasson shared insights into the company's transformative acquisition of NexusBio Ag assets from Univar Solutions. The deal brings a seasoned sales and marketing team, an established product line in the biologics and regenerative agriculture space, and a significant revenue stream that propels MustGrow from pre-revenue status.
MustGrow shares surge after NexusBioAg acquisition finalized
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) shares shot higher on Thursday afternoon in heavy trading following its earlier announcement that it had finalized the acquisition of NexusBio. Shares gained nearly 22% in afternoon trading to reach C$1.40 at the close in Toronto.
MustGrow Biologics wraps up NexusBio acuqisition
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) said it has closed the acquisition of crop nutrition company NexusBioAg assets from Univar Solutions Canada Ltd. The acquisition provides MustGrow with a Canadian sales, marketing, and distribution division, with plans to expand operations into the United States.
MustGrow secures $2M private placement, eyes TerraSante production ramp-up
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) has announced a proposed non-brokered private placement to raise approximately $2 million in gross proceeds, with an option to increase the offering by an additional $1 million. Proceeds from the private placement will be used for inventory production for TerraSante, its certified biofertility product.
